Rise Advisors, LLC Kodiak Sciences Inc. Transaction History
Rise Advisors, LLC
- $242 Million
- Q2 2025
A detailed history of Rise Advisors, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 356 shares of KOD stock, worth $1,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
356Holding current value
$1,847% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KOD
# of Institutions
109Shares Held
41.7MCall Options Held
10.9KPut Options Held
700-
Baker Bros. Advisors LP New York, NY17.3MShares$89.8 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$20 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$10.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$8.76 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.33MShares$6.88 Million0.01% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $270M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...